Maia Biotechnology Inc (MAIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,396 | -18,767 | -9,864 | -4,517 | -23,255 |
| Accounts payable and accrued liabilities | 520 | 1,658 | 206 | 359 | -119 |
| Other Working Capital | 1,499 | 5,818 | 856 | 770 | -1,238 |
| Other Operating Activity | 1,533 | -532 | 465 | -814 | 8,907 |
| Operating Cash Flow | $-18,845 | $-11,824 | $-8,338 | $-4,202 | $-15,705 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 18,524 | 13,603 | 9,251 | 5,666 | 18,972 |
| Other Financing Activity | -617 | -498 | -381 | -205 | -795 |
| Financing Cash Flow | $17,907 | $13,104 | $8,869 | $5,461 | $18,177 |
| Exchange Rate Effect | -5 | 10 | 11 | 3 | -22 |
| Beginning Cash Position | 9,601 | 9,601 | 9,601 | 9,601 | 7,151 |
| End Cash Position | 8,658 | 10,892 | 10,145 | 10,863 | 9,601 |
| Net Cash Flow | $-943 | $1,290 | $543 | $1,262 | $2,451 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,845 | -11,824 | -8,338 | -4,202 | -15,705 |
| Free Cash Flow | -18,845 | -11,824 | -8,338 | -4,202 | -15,705 |